Related Experiment Video

Updated: May 10, 2026

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Anticancer efficiency of reovirus in normoxia and hypoxia

K Figová1, J Hraběta, T Eckschlager

  • 1Department of Paediatric Haematology and Oncology, Charles University in Prague - Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.

Folia Biologica
|June 11, 2013
PubMed

Insights

Reovirus (RV) effectively infects and kills brain tumor cells, even under low-oxygen conditions that typically cause treatment resistance. This oncolytic virus demonstrates potential for treating hypoxic brain tumors.

Area of Science:

  • Oncology
  • Virology
  • Cancer Biology

Background:

  • Oncolytic viruses selectively target and destroy tumor cells while sparing normal cells.
  • Reovirus (RV), a naturally occurring replication-competent virus, preferentially lyses tumor cells with activated Ras signaling pathways.
  • Hypoxia in the tumor microenvironment often leads to resistance against radio- and chemotherapy.

Purpose of the Study:

  • To investigate the effects of reovirus (RV) on brain tumor-derived cells in vitro under hypoxic conditions.
  • To determine if RV can overcome hypoxia-induced resistance in tumor cells.

Main Methods:

  • In vitro culture of brain tumor-derived cells under hypoxic conditions (1% O₂).
  • Infection of tumor cells with reovirus (RV).
  • Assessment of RV replication, cytopathic effect, and cell death mechanisms.

Main Results:

  • RV preferentially replicates in tumor cells.
  • RV successfully infects and kills hypoxic tumor cells, overcoming cellular adaptation to low oxygen.
  • RV induces significant cell death in hypoxic tumor cells via caspase-independent mechanisms.
  • Autophagy was not identified as a mechanism for RV-induced cell death in hypoxia.

Conclusions:

  • Reovirus (RV) is effective against hypoxic brain tumor cells in vitro.
  • RV demonstrates potential as a therapeutic agent for brain tumors, particularly in the resistant hypoxic microenvironment.
  • RV-induced cell death in hypoxia occurs through non-apoptotic, non-autophagic pathways.

More Related Videos

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...